XMax Inc
XMAX
8.74
-0.01
-0.06%
XMax Inc
US · XMAX
#3664 by market cap
8.74
-0.01
-0.06%
Live - 5344 symbols - heartbeat 165s ago
· 2026-10-08 10:11
Pre-market
8.75
+0.11%
After-hours
8.74
0.00%
- Market cap
- 566.69M
- P/E (TTM)i
- 17.47
- P/Bi
- 5.33
- EPSi
- -0.17
- Div yieldi
- 0.00%
- 52W posi
- 86%
Reader sentiment
Are you bullish or bearish on XMAX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 43.32, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +72.63% YoY
Margins
- Gross margin
- 25.02%
- Operating margin
- -11.53%
- Net margin
- -20.44%
Key ratios & quality
- Enterprise valuei
- 566.17M
- Altman Z-Scorei
- 43.32
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 81.18M | 21.98M | 11.35M | 12.56M | 12.74M | 11.09M | 9.69M | 16.72M |
| Gross profit | 15.36M | 1.29M | -19.89M | 5.52M | -7.78M | 4.17M | 4.25M | 4.18M |
| Selling & admin expenses | 10.53M | 7.09M | 6.41M | 9.38M | 8.43M | 7.47M | 7.61M | 6.11M |
| Research & development | -- | -- | -- | -- | 10.92K | 3.12M | 2.00M | 0 |
| Operating profit | 4.83M | -5.80M | -26.30M | -3.86M | -16.22M | -6.42M | -5.36M | -1.93M |
| Pretax profit | 4.52M | -5.89M | -26.40M | -4.06M | -17.07M | -6.99M | -5.56M | -4.00M |
| Tax | -738.77K | 251.04K | -649.17K | 163.89K | 2.40K | 731.09K | 2.61K | -580.99K |
| Net profit | 5.30M | -8.60M | -26.08M | -19.96M | -17.10M | -7.72M | -5.56M | -3.42M |
| Basic EPS | 5 | -8 | -23 | -16 | -12 | -5 | -1 | 0 |
| Diluted EPS | 4.65 | -7.60 | -22.70 | -16.35 | -12.34 | -4.96 | -1.48 | -0.17 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.64M | 2.56M | 9.76M | 1.77M | 1.78M | 2.74M |
| Gross profit | 1.20M | 1.28M | 983.80K | 712.41K | 882.47K | 1.09M |
| Selling & admin expenses | 1.40M | 1.48M | 1.47M | 1.76M | 1.42M | 2.31M |
| Research & development | 390 | 520 | 272 | -1.18K | 0 | 0 |
| Operating profit | -193.36K | -196.49K | -490.02K | -1.05M | -534.85K | -1.22M |
| Pretax profit | -401.13K | -290.90K | -1.13M | -2.18M | 191.51K | 40.24M |
| Tax | -62.26K | -997 | -757 | -516.97K | 0 | 7.81M |
| Net profit | -338.87K | -289.91K | -1.13M | -1.66M | 191.51K | 32.43M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | -0.03 | -0.02 | -0.06 | -0.04 | 0.00 | 0.53 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 85.45M | 68.50M | 43.29M | 25.57M | 8.20M | 3.75M | 7.93M | 11.78M |
| Cash & ST investments | 243.55K | 7.42M | 8.74M | 6.28M | 1.37M | 369.14K | 161.90K | 6.71M |
| Inventory | 6.37M | 29.72M | 32.81M | 2.63M | 4.93M | 2.21M | 2.82M | 2.16M |
| Total assets | 90.09M | 71.56M | 46.48M | 29.53M | 11.53M | 6.24M | 9.92M | 35.55M |
| Total current liabilities | 11.83M | 1.46M | 2.03M | 1.81M | 1.64M | 3.69M | 5.83M | 2.39M |
| Short-term debt | 6.25M | 481.07K | 688.08K | 731.28K | 736.43K | 701.99K | 1.15M | 1.01M |
| Long-term debt | -- | -- | 150.00K | 150.00K | 150.00K | 147.43K | 197.83K | 5.18M |
| Total liabilities | 15,184,553.00 | 5,509,047.00 | 5,550,047.00 | 6,085,436.00 | 4,921,666.00 | 5,742,124.00 | 6,793,889.00 | 7,587,761.00 |
| Total equity | 74.91M | 66.05M | 40.93M | 23.44M | 6.61M | 496.35K | 3.12M | 27.96M |
| Retained earnings | 35.03M | 26.43M | 351.37K | -19.60M | -36.71M | -44.43M | -49.99M | -53.41M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 10.36M | 10.24M | 12.27M | 11.78M | 19.71M | 46.94M |
| Cash & ST investments | 147.30K | 468.83K | 1.71M | 6.71M | 9.91M | 34.63M |
| Inventory | 2.11M | 1.58M | 2.25M | 2.16M | 1.66M | 1.94M |
| Total assets | 11.93M | 11.63M | 18.29M | 35.55M | 47.14M | 121.08M |
| Total current liabilities | 4.37M | 4.49M | 4.41M | 2.39M | 1.52M | 1.63M |
| Short-term debt | 932.69K | 1.15M | 1.12M | 1.01M | 846.28K | 263.31K |
| Long-term debt | 207.41K | 210.19K | 204.11K | 5.18M | 5.25M | 5.33M |
| Total liabilities | 5,153,587.00 | 5,087,783.00 | 4,702,583.00 | 7,587,761.00 | 6,789,050.00 | 14,781,683.00 |
| Total equity | 6.77M | 6.55M | 13.58M | 27.96M | 40.35M | 106.30M |
| Retained earnings | -50.33M | -50.62M | -51.75M | -53.41M | -53.22M | -20.79M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -6.88M | 14.89M | -2.08M | -4.78M | -5.37M | -1.58M | -1.39M | -445.84K |
| Depreciation & amortization | 37.68K | 510.78K | 747.81K | 846.52K | 571.85K | 803.79K | 510.20K | 882.74K |
| Free cash flow | -6.91M | 14.86M | -2.44M | -4.89M | -5.38M | -1.58M | -1.41M | -445.84K |
| Dividends paid | -- | -- | -- | -- | -- | -- | 0 | 0 |
| Stock buybacks / issuance | 0 | -616.19K | 0 | 2.76M | -- | 0 | 750.00K | 24.67M |
| Ending cash balance | 890.41K | 8.89M | 8.74M | 6.28M | 1.37M | 369.14K | 161.90K | 6.71M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -322.62K | 92.51K | -1.91M | 1.69M | -641.74K | -3.65M |
| Depreciation & amortization | 198.08K | 200.33K | 183.54K | 300.80K | 162.50K | 184.38K |
| Free cash flow | -322.62K | 92.51K | -1.91M | 1.69M | -641.74K | -3.65M |
| Dividends paid | 0 | 0 | -- | -- | 0 | 0 |
| Stock buybacks / issuance | 500.00K | 0 | 0 | 24.17M | 12.20M | 33.51M |
| Ending cash balance | 147.30K | 468.83K | 1.71M | 6.71M | 9.91M | 34.63M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 7.39 | -12.20 | -48.76 | -62.02 | -113.80 | -217.31 | -307.29 | -22.00 |
| ROA %i | 6.24 | -10.64 | -44.19 | -52.53 | -83.29 | -86.92 | -68.85 | -15.04 |
| ROIC %i | 6.80 | -11.31 | -46.46 | -56.70 | -94.04 | -127.89 | -141.15 | -17.02 |
| 5-year avg ROE %i | 6.83 | 0.61 | -9.93 | -21.97 | -45.88 | -90.82 | -149.83 | -144.48 |
| EBIT margin %i | 5.58 | -26.37 | -231.76 | -154.49 | -127.29 | -57.89 | -57.06 | -23.46 |
| FCF / sales %i | -- | 67.59 | -- | -- | -- | -- | -- | -- |
| Current ratioi | 7.22 | 46.77 | 21.38 | 14.09 | 4.99 | 1.02 | 1.36 | 4.92 |
| Quick ratioi | 5.65 | 5.35 | 4.88 | 3.68 | 1.06 | 0.12 | 0.04 | 3.83 |
| Debt / assetsi | 6.94 | 3.76 | 5.56 | 11.71 | 24.78 | 33.85 | 21.34 | 17.47 |
| LT debt / equityi | -- | 3.35 | 4.63 | 11.63 | 32.08 | 284.01 | 31.01 | 18.58 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -176.93 | -50.85 |
| Revenue CAGR (3Y) %i | -3.36 | -38.09 | -52.59 | -46.32 | -16.62 | -0.78 | -8.28 | 9.48 |
| Net income CAGR (3Y) %i | 34.05 | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -131.84 | -126.29 | -44.52 | -22.00 | -12.26 | 52.87 |
| ROA %i | -49.01 | -47.76 | -24.20 | -15.04 | -9.78 | 44.95 |
| ROIC %i | -83.86 | -79.59 | -35.20 | -17.02 | -10.51 | 49.63 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -42.56 | -40.06 | -11.88 | -23.46 | -26.87 | -32.93 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.37 | 2.28 | 2.78 | 4.92 | 12.96 | 28.80 |
| Quick ratioi | 0.06 | 0.12 | 2.19 | 3.83 | 11.68 | 26.55 |
| Debt / assetsi | 14.41 | 15.05 | 7.72 | 17.47 | 12.97 | 4.63 |
| LT debt / equityi | 11.61 | 9.19 | 2.13 | 18.58 | 13.06 | 5.03 |
| Interest coveragei | -- | -- | -- | -50.85 | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Sale of residential and commercial furniture is the largest reported line at 59.88% of revenue, across 2 reported segments.
- Application Programming Interface (API)-based service follows at 40.12%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Sale of residential and commercial furniture59.88%
Application Programming Interface (API)-based service40.12%
Quote time 2026-10-08 10:11:00 · For reference only, not investment advice and not tailored to your situation.